EPLAW PATENT BLOG

EU – Council adopts regulation introducing SPC stockpiling / export exception

Posted: May 15th, 2019

From the press release: “The EU is taking measures to foster the competitiveness of EU producers of generic medicines and biosimilar products. The Council today adopted a regulation which introduces an exception to the protection granted to an original medicine by a supplementary protection certificate (SPC) for export purposes and/or for stockpiling. “Thanks to the […]

READ MORE

EU – Export and stockpiling exception

Posted: February 21st, 2019

The EU is about to introduce an export and stockpiling exception, limiting the protection granted to SPC holders. From the press release: “The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products. Member states’ ambassadors meeting today in Coreper endorsed a deal reached on 14 […]

READ MORE

News – Dutch AIPPI ‘Zeist’ symposium 2019

Posted: January 24th, 2019

The Dutch AIPPI ‘Zeist’ symposium shall take place on 13 March 2019 in Hotel Figi in Zeist. The programme and registration details will be announced here.

READ MORE

ES – Mobile World Congress IP Fast Action Protocol 2019

Posted: January 11th, 2019

MOBILE WORLD CONGRESS – INTELLECTUAL PROPERTY FAST ACTION PROTOCOL 2019, by Luis Fernández-Novoa, HOYNG ROKH MONEGIER The Commercial Courts of Barcelona have issued for the fifth consecutive year the Intellectual Property Fast Action Protocol in the framework of the Mobile World Congress (hereinafter MWC). The upcoming edition will be held in Barcelona from 25 to […]

READ MORE

CJEU – Abraxis Bioscience LLC v. Comptroller General of Patents / Opinion AG / SPC

Posted: January 7th, 2019

Abraxis Bioscience LLC v. Comptroller General of Patents, Opinion of AG SAUGMANDSGAARD ØE, 13 December 2018, Case C‑443/17 In the light of all the foregoing considerations, I propose that the Court give the following answer to the question referred by the High Court of Justice (England & Wales), Chancery Division (Patents Court), United Kingdom: Article […]

READ MORE

News – Book: Intellectual Property and the Judiciary

Posted: November 27th, 2018

Intellectual Property and the Judiciary, European Intellectual Property Institute Network series, Elgar, edited by Christophe Geiger, Craig Allen and Xavier Seuba “Intellectual Property and the Judiciary explores the role of the judiciary in the elaboration and interpretation of intellectual property law, exploring how IP doctrine and policy are developed and the manner in which judges […]

READ MORE

New Book – Patent Wars, How Patents Impact our Daily Lives

Posted: September 14th, 2018

Oxford University Press presents a new book providing a broader view on patent law and the role of patents in society. Central message from the author of the book is that “there’s so much we don’t know for sure, even after all these years of granting, revoking, licensing, and fighting over patents. Do patents really […]

READ MORE

New book – Unified Patent Protection in Europe – A Commentary / Winfried Tilmann and Clemens Plassmann

Posted: August 21st, 2018

Appearance of the book “Unified Patent Protection in Europe – A Commentary” edited by Winfried Tilmann and Clemens Plassmann Oxford University Press, Oxford, July 2018, 3040 pages, 246×171 mm, 335 €, ISBN 9780198755463, www.oup.com/uk/law It is a privilege to be the first to read a new Bible! That word is no exaggeration, because this commentary […]

READ MORE

EU – EC proposes ‘export manufacturing waiver’ to SPC’s

Posted: May 29th, 2018

The European Commission on 28 May proposed a so-called ‘export manufacturing waiver’ to Supplementary Protection Certificates. “The Commission is proposing a targeted adjustment to intellectual property rules to help Europe’s pharmaceutical companies tap into fast-growing global markets and foster jobs, growth and investments in the EU.” A copy of the EC press release can be […]

READ MORE

NL – Dutch Competition Authority Working Paper on Dominance abuse and patented pharmaceuticals / excessive pricing

Posted: March 22nd, 2018

Chris Fonteijn, Ilan Akker and Wolf Sauter, ACM Working Paper, March 2018, Reconciling competition and IP law: the case of patented pharmaceuticals and dominance abuse Chris Fonteijn is Chairman of the Dutch authority for consumers and markets (ACM). Ilan Akker and Wolf Sauter work in the Healthcare Taskforce of ACM. Wolf Sauter is also professor of […]

READ MORE